United Therapeutics (UTHR) Interest Coverage Ratio (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Interest Coverage Ratio data on file, last reported at 0.18 in Q1 2026.

• For the quarter ending Q1 2026, Interest Coverage Ratio fell 58.34% year-over-year to 0.18; the trailing twelve-month figure through Mar 2026 stood at 0.81 (down 49.93% YoY), and the FY2025 full-year result was 76.54, up 138.45% from the prior year.
• Interest Coverage Ratio eased to 0.18 in Q1 2026, from 115.06 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 115.06 in Q4 2025 to a low of 0.18 in Q1 2026.
• A 5-year average of 13.01 and a median of 0.54 in 2022 frame the typical range for Interest Coverage Ratio.
• Peak annual rise in Interest Coverage Ratio reached 461.47% in 2022, while the deepest fall reached 60.48% in 2022.
• Tracing UTHR's Interest Coverage Ratio over 5 years: stood at 14.28 in 2022, then climbed by 20.65% to 17.23 in 2023, then surged by 299.35% to 68.79 in 2024, then jumped by 67.27% to 115.06 in 2025, then sank by 99.84% to 0.18 in 2026.
• Business Quant data shows UTHR's Interest Coverage Ratio at 0.18 in Q1 2026, 115.06 in Q4 2025, and 0.28 in Q3 2025.